Kecheng Xu
- Oncology top 5%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Hepatology top 2%
- Surgery top 10%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (24 papers)Pancreatic and Hepatic Oncology Research (20 papers)Cancer Cells and Metastasis (12 papers)
- Cited by
- HepatologyOncologyImmunology
- Journals
- SHILAP Revista de lepidopterologíaGastroenterologyPLoS ONE
In The Last Decade
Kecheng Xu
82 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 90
- Oncology 791
- Immunology 438
- Pulmonary and Respiratory Medicine 389
- Hepatology 312
- Surgery 308
Countries citing papers authored by Kecheng Xu
This map shows the geographic impact of Kecheng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kecheng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kecheng Xu more than expected).
Fields of papers citing papers by Kecheng Xu
This network shows the impact of papers produced by Kecheng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kecheng Xu. The network helps show where Kecheng Xu may publish in the future.
Co-authorship network of co-authors of Kecheng Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Kecheng Xu. A scholar is included among the top collaborators of Kecheng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kecheng Xu. Kecheng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 11 | |
| 3 | 13 | |
| 4 | 23 | |
| 5 | 46 | |
| 6 | 32 | |
| 7 | 4 | |
| 8 | 41 | |
| 9 | 9 | |
| 10 | 8 | |
| 11 | 4 | |
| 12 | 12 | |
| 13 | 13 | |
| 14 | 5 | |
| 15 | 31 | |
| 16 | 15 | |
| 17 | 11 | |
| 18 | 42 | |
| 19 | 50 | |
| 20 | 45 |
About Kecheng Xu
Kecheng Xu is a scholar working on Hepatology, Biotechnology and Oncology, having authored 82 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Pancreatic and Hepatic Oncology Research (20 papers) and Cancer Cells and Metastasis (12 papers). The work is most often cited by research in Hepatology (312 citations), Oncology (791 citations) and Immunology (438 citations). Kecheng Xu has collaborated with scholars based in China, Australia and Austria. Frequent co-authors include Lizhi Niu, Jibing Chen, Shuzhen Liang, Mao Lin, Feng Mu, Jiansheng Zuo, Lizhi Niu, Mingjie Zhang, Jialiang Li and Jianying Zeng. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.